MyBlueDots

Stimulant users are caught in fatal ‘fourth wave’ of opioid epidemic

MyBlueDots4 weeks ago01 mins

In Pawtucket, Rhode Island, near a storefront advertising “free” cellphones, J.R. sat in an empty back stairwell and showed a reporter how he tries to avoid overdosing when he smokes crack cocaine. KFF Health News is identifying him by his initials because he fears being arrested for using illegal drugs.

Researchers enhance automated method to detect common sleep disorder affecting millions

MyBlueDots4 weeks ago01 mins

A Mount Sinai-led team of researchers has enhanced an artificial intelligence (AI)-powered algorithm to analyze video recordings of clinical sleep tests, ultimately improving accurate diagnosis of a common sleep disorder affecting more than 80 million people worldwide.

ORACLE lung cancer test predicts survival in early stages better than current methods

MyBlueDots4 weeks ago01 mins

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help doctors make more informed treatment decisions for people with stage 1 lung cancer, potentially reducing the risk of the cancer returning or spreading.

Dementia diagnosis: How long do patients really live?

MyBlueDots4 weeks ago01 mins

The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for women and from 6.5 to just over two years, respectively, in men, finds a systematic review of the latest evidence in The BMJ.

Health insurers limit coverage of prosthetic limbs, questioning their medical necessity

MyBlueDots4 weeks ago01 mins

When Michael Adams was researching health insurance options in 2023, he had one very specific requirement: coverage for prosthetic limbs.

Extended nirmatrelvir/ritonavir found to be beneficial for some with long COVID

MyBlueDots4 weeks ago01 mins

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series published online Jan. 6 in Communications Medicine.

Study finds 1 in 4 older U.S. veterans report cardiovascular disease diagnosis

MyBlueDots4 weeks ago01 mins

One in four older U.S. veterans report being diagnosed with cardiovascular disease (CVD) in their lifetime, according to a study published online Dec. 18 in PLOS Mental Health.

Research shows 8 in 10 infants received RSV protection in the 2023 to 2024 season

MyBlueDots4 weeks ago01 mins

Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online Jan. 8 in JAMA Network Open.

MyBlueDots

Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

MyBlueDots4 weeks ago01 mins

PONTE VEDRA, Fla.–(BUSINESS WIRE)–Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), today announced that Chairman and Chief Executive Officer, Quang X. Pham, will participate in a webcasted fireside chat at the Lytham Partners 2025 Investor Healthcare Summit, taking place virtually on Monday, January 13, 2025. Cadrenal Therapeutics is a biopharmaceutical company focused on developing tecarfarin, a novel oral vitamin K antagonist (VKA) in advanced clinical development and designed to be a superior

MyBlueDots

Transcatheter Aortic Valve Replacement (TAVR) Embolic Protection Market Forecast Report 2024-2025 & 2030: Surge in Minimally Invasive Cardiovascular Treatments, and Technological Advancements – ResearchAndMarkets.com

MyBlueDots4 weeks ago01 mins

DUBLIN–(BUSINESS WIRE)–The “TAVR Embolic Protection Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by End-User, Mode of Development, Product Type, Region, By Country: 2020-2030” report has been added to ResearchAndMarkets.com’s offering. Transcatheter Aortic Valve Replacement (TAVR) Embolic Protection market reveals a burgeoning expansion with the market valuation anticipated to experience an impressive Compound Annual Growth Rate (CAGR) of 14.2% between 2025 and 2030. T

Useful _Links

Generally, things really do seem better in the morning, large study suggests

GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds

Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics

‘Good’ cholesterol may be linked to heightened glaucoma risk among over 55s

New insights into liver maturation and specialization could advance regenerative medicine

Research shows positive changes in opioid prescribing, but trend among young people a cause for concern

Stimulant users are caught in fatal ‘fourth wave’ of opioid epidemic

Researchers enhance automated method to detect common sleep disorder affecting millions

ORACLE lung cancer test predicts survival in early stages better than current methods

Dementia diagnosis: How long do patients really live?

Health insurers limit coverage of prosthetic limbs, questioning their medical necessity

Extended nirmatrelvir/ritonavir found to be beneficial for some with long COVID

Study finds 1 in 4 older U.S. veterans report cardiovascular disease diagnosis

Research shows 8 in 10 infants received RSV protection in the 2023 to 2024 season

Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Transcatheter Aortic Valve Replacement (TAVR) Embolic Protection Market Forecast Report 2024-2025 & 2030: Surge in Minimally Invasive Cardiovascular Treatments, and Technological Advancements – ResearchAndMarkets.com

World News

Useful Links

Health

Business

Entertainment

About Us